XML 64 R43.htm IDEA: XBRL DOCUMENT v3.25.4
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Restricted Stock Award and Performance Award Activity
The following table summarizes the status of the restricted stock award activity for the year ended December 31, 2025:
SharesWeighted Average Share Price
Unvested balance at December 31, 2024552,999 $23.86 
Granted:
RSAs148,495 27.29 
Board Awards20,148 28.79 
Vested(167,663)21.52 
Unvested balance at December 31, 2025553,979 $25.67 
Schedule of Award Grants
The following table summarizes the Company’s RSA and Board Award grants during the year ended December 31, 2025 (dollars in thousands, except per share amounts):
GrantsVested
SharesWeighted Average Share PriceGrant Date Fair ValueSharesVest Date Fair Value
During year ended December 31, 2025(1)
RSAs148,495 $27.29 $4,052 145,951 $3,868 
Board Awards20,148 28.79 580 21,712 610 
(1)The Compensation Committee granted annual awards for 2026 in January 2026.
The following table summarizes the Company’s RSA and Board Award grants during the years ended December 31, 2024 and 2023 (dollars in thousands, except per share amounts):
Grants
SharesWeighted Average Share PriceGrant Date Fair Value
During year ended December 31, 2024(1)
RSAs225,815 $27.38 $6,183 
Board Awards21,712 23.95 520 
During year ended December 31, 2023(2)
RSAs166,122 $22.41 $3,722 
Board Awards24,768 19.38 480 
(1)The Compensation Committee granted annual awards for 2025 in December 2024.
(2)The Compensation Committee granted annual awards for 2024 in December 2023.
Schedule of Key Valuation Assumptions Used in Valuation
The fair value of the TSR Units is estimated on the date of the grant using a Monte Carlo valuation model. The risk-free rate is based on the U.S. Treasury yield curve in effect at the grant date for the expected performance period. Expected volatility is based on historical volatility for the most recent weighted average period ending on the grant date for the Company and the selected TSR peer group, and is calculated on a daily basis. The following table reflects the weighted-average key assumptions used in this valuation for awards granted during the years ended December 31, 2024 and 2023:
For the Year Ended December 31, 2024
For the Year Ended December 31, 2023
Risk-free interest rate4.30 %4.08 %
Expected stock price volatility24.45 %26.44 %
Expected service period3.03 years3.04 years
Expected dividend yield (assuming full reinvestment)— %— %
Weighted average fair value per share at date of grant$34.10 $27.41 
Schedule of Stock-Based Compensation Expense
The following table summarizes the stock-based compensation expense recognized (dollars in thousands):
 
For the Year Ended December 31,
 202520242023
Stock-based compensation expense$11,896 $6,130 $5,153